Synthesis and anti-migrative evaluation of moverastin derivatives

Masato Sawada, Shin Ichiro Kubo, Koji Matsumura, Yasushi Takemoto, Hiroki Kobayashi, Etsu Tashiro, Takeshi Kitahara, Hidenori Watanabe, Masaya Imoto

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cell migration of tumor cells is essential for invasion of the extracellular matrix and for cell dissemination. Inhibition of the cell migration involved in the invasion process represents a potential therapeutic approach to the treatment of tumor metastasis; therefore, a novel series of derivatives of moverastins (moverastins A and B), an inhibitor of tumor cell migration, was designed and chemically synthesized. Among these moverastin derivatives, several compounds showed stronger cell migration inhibitory activity than parental moverastins, and UTKO1 was found to have the most potent inhibitory activity against the migration of human esophageal tumor EC17 cells in a chemotaxis cell chamber assay. Interestingly, although moverastins are considered to inhibit tumor cell migration by inhibiting farnesyltransferase (FTase), UTKO1 did not inhibit FTase, indicating that UTKO1 inhibited tumor cell migration by a mechanism other than the inhibition of FTase.

Original languageEnglish
Pages (from-to)1385-1389
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume21
Issue number5
DOIs
Publication statusPublished - 2011 Mar 1

Fingerprint

Tumors
Cell Movement
Farnesyltranstransferase
Derivatives
Cells
Neoplasms
Cell Migration Inhibition
Chemotaxis
Extracellular Matrix
Assays
Neoplasm Metastasis
Therapeutics
moverastin A

Keywords

  • Cell migration
  • Chemical synthesis
  • UTKO1

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Synthesis and anti-migrative evaluation of moverastin derivatives. / Sawada, Masato; Kubo, Shin Ichiro; Matsumura, Koji; Takemoto, Yasushi; Kobayashi, Hiroki; Tashiro, Etsu; Kitahara, Takeshi; Watanabe, Hidenori; Imoto, Masaya.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 21, No. 5, 01.03.2011, p. 1385-1389.

Research output: Contribution to journalArticle

Sawada, M, Kubo, SI, Matsumura, K, Takemoto, Y, Kobayashi, H, Tashiro, E, Kitahara, T, Watanabe, H & Imoto, M 2011, 'Synthesis and anti-migrative evaluation of moverastin derivatives', Bioorganic and Medicinal Chemistry Letters, vol. 21, no. 5, pp. 1385-1389. https://doi.org/10.1016/j.bmcl.2011.01.028
Sawada, Masato ; Kubo, Shin Ichiro ; Matsumura, Koji ; Takemoto, Yasushi ; Kobayashi, Hiroki ; Tashiro, Etsu ; Kitahara, Takeshi ; Watanabe, Hidenori ; Imoto, Masaya. / Synthesis and anti-migrative evaluation of moverastin derivatives. In: Bioorganic and Medicinal Chemistry Letters. 2011 ; Vol. 21, No. 5. pp. 1385-1389.
@article{7d24364b2acb4844a481a218bb5d383d,
title = "Synthesis and anti-migrative evaluation of moverastin derivatives",
abstract = "Cell migration of tumor cells is essential for invasion of the extracellular matrix and for cell dissemination. Inhibition of the cell migration involved in the invasion process represents a potential therapeutic approach to the treatment of tumor metastasis; therefore, a novel series of derivatives of moverastins (moverastins A and B), an inhibitor of tumor cell migration, was designed and chemically synthesized. Among these moverastin derivatives, several compounds showed stronger cell migration inhibitory activity than parental moverastins, and UTKO1 was found to have the most potent inhibitory activity against the migration of human esophageal tumor EC17 cells in a chemotaxis cell chamber assay. Interestingly, although moverastins are considered to inhibit tumor cell migration by inhibiting farnesyltransferase (FTase), UTKO1 did not inhibit FTase, indicating that UTKO1 inhibited tumor cell migration by a mechanism other than the inhibition of FTase.",
keywords = "Cell migration, Chemical synthesis, UTKO1",
author = "Masato Sawada and Kubo, {Shin Ichiro} and Koji Matsumura and Yasushi Takemoto and Hiroki Kobayashi and Etsu Tashiro and Takeshi Kitahara and Hidenori Watanabe and Masaya Imoto",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.bmcl.2011.01.028",
language = "English",
volume = "21",
pages = "1385--1389",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Synthesis and anti-migrative evaluation of moverastin derivatives

AU - Sawada, Masato

AU - Kubo, Shin Ichiro

AU - Matsumura, Koji

AU - Takemoto, Yasushi

AU - Kobayashi, Hiroki

AU - Tashiro, Etsu

AU - Kitahara, Takeshi

AU - Watanabe, Hidenori

AU - Imoto, Masaya

PY - 2011/3/1

Y1 - 2011/3/1

N2 - Cell migration of tumor cells is essential for invasion of the extracellular matrix and for cell dissemination. Inhibition of the cell migration involved in the invasion process represents a potential therapeutic approach to the treatment of tumor metastasis; therefore, a novel series of derivatives of moverastins (moverastins A and B), an inhibitor of tumor cell migration, was designed and chemically synthesized. Among these moverastin derivatives, several compounds showed stronger cell migration inhibitory activity than parental moverastins, and UTKO1 was found to have the most potent inhibitory activity against the migration of human esophageal tumor EC17 cells in a chemotaxis cell chamber assay. Interestingly, although moverastins are considered to inhibit tumor cell migration by inhibiting farnesyltransferase (FTase), UTKO1 did not inhibit FTase, indicating that UTKO1 inhibited tumor cell migration by a mechanism other than the inhibition of FTase.

AB - Cell migration of tumor cells is essential for invasion of the extracellular matrix and for cell dissemination. Inhibition of the cell migration involved in the invasion process represents a potential therapeutic approach to the treatment of tumor metastasis; therefore, a novel series of derivatives of moverastins (moverastins A and B), an inhibitor of tumor cell migration, was designed and chemically synthesized. Among these moverastin derivatives, several compounds showed stronger cell migration inhibitory activity than parental moverastins, and UTKO1 was found to have the most potent inhibitory activity against the migration of human esophageal tumor EC17 cells in a chemotaxis cell chamber assay. Interestingly, although moverastins are considered to inhibit tumor cell migration by inhibiting farnesyltransferase (FTase), UTKO1 did not inhibit FTase, indicating that UTKO1 inhibited tumor cell migration by a mechanism other than the inhibition of FTase.

KW - Cell migration

KW - Chemical synthesis

KW - UTKO1

UR - http://www.scopus.com/inward/record.url?scp=79951726913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951726913&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2011.01.028

DO - 10.1016/j.bmcl.2011.01.028

M3 - Article

C2 - 21306898

AN - SCOPUS:79951726913

VL - 21

SP - 1385

EP - 1389

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 5

ER -